Page last updated: 2024-08-22

camptothecin and pasireotide

camptothecin has been researched along with pasireotide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almhanna, K; Fulp, W; Kim, R; Mahipal, A; Shibata, D; Siegel, E; Springett, G; Williams-Elson, I	1

Trials

1 trial(s) available for camptothecin and pasireotide

Article	Year
Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies. Investigational new drugs, 2015, Volume: 33, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Insulin-Like Growth Factor I; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Somatostatin; Survival Analysis	2015

Article

Year

Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.

Investigational new drugs, 2015, Volume: 33, Issue:5

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Insulin-Like Growth Factor I; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Somatostatin; Survival Analysis

2015